Sale of 19,275 shares at $4.66 per share.
Reporting Person Soares Karen · Officer Title Chief Legal Officer · Transaction Code S
Traded Oct 20, 2026 · Disclosed Oct 20, 2026
Source: SEC Form 4 · 0001999086-26-000034 · filed 2026-10-20 · View filing →
Sale of 4,066 shares at $4.41 per share.
Reporting Person Reynoso Jamie L. · Officer Title CEO, Medicare Advantage · Transaction Code S
Traded Oct 19, 2026 · Disclosed Oct 20, 2026
Source: SEC Form 4 · 0001839066-26-000057 · filed 2026-10-20 · View filing →
Sale of 18,273 shares at $4.68 per share.
Reporting Person Reynoso Jamie L. · Officer Title CEO, Medicare Advantage · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 19, 2026
Source: SEC Form 4 · 0001801170-26-000276 · filed 2026-10-19 · View filing →
Sale of 23,627 shares at $4.68 per share.
Reporting Person Wai Conrad · Officer Title CEO, Counterpart Health · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 19, 2026
Source: SEC Form 4 · 0001801170-26-000278 · filed 2026-10-19 · View filing →
Sale of 4,591 shares at $4.68 per share.
Reporting Person THORNTON JOSEPH CLAY · Officer Title Interim CFO · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 19, 2026
Source: SEC Form 4 · 0001801170-26-000280 · filed 2026-10-19 · View filing →
Sale of 14,673 shares at $4.68 per share.
Reporting Person Soares Karen · Officer Title Chief Legal Officer · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 19, 2026
Source: SEC Form 4 · 0001801170-26-000282 · filed 2026-10-19 · View filing →
Sale of 62,176 shares at $4.68 per share.
Reporting Person Toy Andrew · Officer Title Chief Executive Officer · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 19, 2026
Source: SEC Form 4 · 0001801170-26-000284 · filed 2026-10-19 · View filing →
Sale of 2,006 shares at $4.63 per share.
Reporting Person Reynoso Jamie L. · Officer Title CEO, Medicare Advantage · Transaction Code S
Traded Oct 7, 2026 · Disclosed Oct 7, 2026
Source: SEC Form 4 · 0001839066-26-000054 · filed 2026-10-07 · View filing →
Sale of 8,750 shares at $4.42 per share.
Reporting Person Reynoso Jamie L. · Officer Title CEO, Medicare Advantage · Transaction Code S
Traded Oct 5, 2026 · Disclosed Oct 5, 2026
Source: SEC Form 4 · 0001839066-26-000052 · filed 2026-10-05 · View filing →
Sale of 318,806 shares at $4.19 per share.
Reporting Person Toy Andrew · Officer Title Chief Executive Officer · Transaction Code S
Traded Oct 1, 2026 · Disclosed Oct 2, 2026
Source: SEC Form 4 · 0001801170-26-000242 · filed 2026-10-02 · View filing →
Acquisition (code A) of 12,481 shares at $0 per share.
Reporting Person Torricelli Robert G · Transaction Code A
Traded Sep 30, 2026 · Disclosed Oct 2, 2026
Source: SEC Form 4 · 0001801170-26-000243 · filed 2026-10-02 · View filing →
Acquisition (code A) of 12,481 shares at $0 per share.
Reporting Person Miller Brian James · Transaction Code A
Traded Sep 30, 2026 · Disclosed Oct 2, 2026
Source: SEC Form 4 · 0001801170-26-000244 · filed 2026-10-02 · View filing →
Sale of 1,921 shares at $4.56 per share.
Reporting Person Reynoso Jamie L. · Officer Title CEO, Medicare Advantage · Transaction Code S
Traded Sep 17, 2026 · Disclosed Sep 18, 2026
Source: SEC Form 4 · 0001839066-26-000047 · filed 2026-09-18 · View filing →
Sale of 3,170 shares at $4.64 per share.
Reporting Person OLDAKOWSKI JOSEPH FRANK · Officer Title VP OF FINANCE AND CONTROLLER · Transaction Code S
Traded Sep 16, 2026 · Disclosed Sep 17, 2026
Source: SEC Form 4 · 0001801170-26-000223 · filed 2026-09-17 · View filing →
Sale of 300,000 shares at $4.72 per share.
Reporting Person Wai Conrad · Officer Title CEO, Counterpart Health · Transaction Code S
Traded Sep 15, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001971702-26-000017 · filed 2026-09-16 · View filing →
Sale of 9,273 shares at $4.78 per share.
Reporting Person Reynoso Jamie L. · Officer Title CEO, Medicare Advantage · Transaction Code S
Traded Sep 15, 2026 · Disclosed Sep 15, 2026
Source: SEC Form 4 · 0001839066-26-000045 · filed 2026-09-15 · View filing →
Sale of 6,846 shares at $4.78 per share.
Reporting Person Soares Karen · Officer Title Chief Legal Officer · Transaction Code S
Traded Sep 15, 2026 · Disclosed Sep 15, 2026
Source: SEC Form 4 · 0001999086-26-000031 · filed 2026-09-15 · View filing →
Sale of 20,000 shares at $5.16 per share.
Reporting Person OLDAKOWSKI JOSEPH FRANK · Officer Title VP OF FINANCE AND CONTROLLER · Transaction Code S
Traded Sep 14, 2026 · Disclosed Sep 14, 2026
Source: SEC Form 4 · 0001801170-26-000218 · filed 2026-09-14 · View filing →
Sale of 17,775 shares at $4.39 per share.
Reporting Person THORNTON JOSEPH CLAY · Officer Title Interim CFO · Transaction Code S
Traded Aug 17, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001801170-26-000207 · filed 2026-08-17 · View filing →
Acquisition (code A) of 54,347 shares at $0 per share.
Reporting Person THORNTON JOSEPH CLAY · Officer Title Interim CFO · Transaction Code A
Traded Aug 12, 2026 · Disclosed Aug 13, 2026
Source: SEC Form 4 · 0001801170-26-000202 · filed 2026-08-13 · View filing →
Acquisition (code A) of 108,695 shares at $0 per share.
Reporting Person Soares Karen · Officer Title Chief Legal Officer · Transaction Code A
Traded Aug 12, 2026 · Disclosed Aug 13, 2026
Source: SEC Form 4 · 0001999086-26-000023 · filed 2026-08-13 · View filing →